HQ: Plymouth Meeting, PA
Leadership: Jeffrey Aronin, John C. Jacobs
Opportunity: Develop and commercialize novel treatment options for people living with rare, orphan diseases. With a focus on the central nervous system, including disorders of sleep and wakefulness, the company’s goal is to improve the lives of those whose medical conditions could benefit from the potential of first-in-class, mechanism-based treatment approaches.
Vision: Develop and provide new medications to help people who are living with rare diseases.